Both copaiba and CBD also have the ability to protect nerve cells against damage.
CBD oils are generally available as either isolate, broad-spectrum, or full-spectrum options. The former is the purest type of CBD, while the latter two include a range of other beneficial compounds.
For instance, people suffering from symptoms like anxiety might prefer to take CBD orally. As well as coming as an oil, CBD edibles like gummies are a popular choice. Some consumers also enjoy vaping CBD or even smoking CBD-rich cannabis strains.
How to Use Copaiba and CBD
For example, many people use CBD oil to help relieve symptoms like anxiety or sleep problems. It may also be helpful for people suffering from addictions or psychosis. However, these benefits are not generally associated with copaiba.
These trees produce a resin that is rich in aromatic compounds called terpenes. These chemicals give the resin its distinctive smell and also have a variety of potential health benefits.
CBD vs. Copaiba: Similarities and Differences Explained
A 2018 review for Surgical Neurology International found CBD to have similar effects. It appears to offer protection against brain damage via several distinct mechanisms. They include reducing inflammation and improving circulation. It also increases the brain’s levels of adenosine, a chemical with neuroprotective effects.
Copaiba has featured heavily in Central and South American folk medicine for centuries. However, it has only recently gained popularity across the globe.
At the 2019 Together Convention, doTERRA’s Director of Education and Training, Scott Johnson, said, “Copaiba and CBD work within the same biological system, so people naturally want to compare them, but it’s not really a fair comparison[…]Copaiba has benefits that can’t be achieved with CBD.”
Exemplifying doTERRA’s commitment to Pursue What’s Pure, Copaiba is a product born from that standard. Unlike CBD, essential oils rich in BCP, such as Copaiba, are easily tolerated compounds that offer countless benefits to the human body. At this year’s convention, Scott highlighted other possible targets and pathways for BCP outside the ECS such as the CD14 receptor, the μ-Opioid receptor, and the α7-nACHRs receptor.* These receptors affect pathways associated with healthy inflammatory response 3 , overall body comfort, and cognitive function.
CB1 and CB2 Receptors
There are three groups of molecules that can greatly affect the function of the ECS: endocannabinoids (produced by the body), phytocannabinoids (produced by plants), and synthetic cannabinoids (produced in a lab). Phytocannabinoids are different because they are produced naturally by plants, such as Cannabis, Black Truffle, and Cacao, and found within essential oils such as Copaiba, Black Pepper, and Melissa.
Because CBD does not bind directly to receptors, you can expect slower cellular responses. Scott Johnson said it best at convention describing CBD as a “helper molecule that signals the ECS to work more efficiently and modulate our responses to the molecules that do directly bind to our receptors.” Furthermore, as doTERRA’s in-house GCMS testing has shown, CBD—which is an isolate extracted from the cannabis plant—is often mixed with carrier oils, so absorption is limited and the effect is further decreased. In fact, a recent review of clinical data on CBD revealed internal usage may come with potential unwanted risks 4 .
The Advantages of Copaiba
In addition, according to a study published in 2017, 69% of CBD products were mislabeled and found to have higher levels of THC than are currently permitted by regulations 5 . This poses regulatory challenges and also increased risk for unwanted side effects. Not only can formulations of CBD contain some amount of THC 6 , but as previously mentioned, CBD is not an essential oil, it’s an isolate extracted from the cannabis plant. For doTERRA, the fact that it is nearly impossible for CBD to meet CPTG Certified Pure Tested Grade™ standards for purity and potency is reason enough to keep it out of the product line.